← All people

Other insiders

Xichen Lin

Transactions disclosed by this reporting insider. Insider filers can be individuals or organisations.

Source last checked 2026-10-12 01:37 UTC. Reporting dates appear with the records.

Stock growth & value

Stocks linked to collected disclosures. Prices refresh in the background; the chart shows its actual price dates.

Latest stored close
$25.54
GPCR · 2026-10-09 · USD
Stock price change
−$4.59
-15.23% over the displayed dates
Chart dates
2025-10-14 – 2026-10-09
Completed daily price dates

Stock price · move across the chart or use arrow keys

Oct 14, 2025Oct 9, 2026
Starting investment
$10K
2025-10-14 · hypothetical
Investment value
$8.5K
As of 2026-10-09
Estimated gain / loss
−$1,523.40
-15.23%

Illustration assumes buying this stock at the first displayed close and holding through the last. It does not represent this person's investment or earnings. Uses stored split-adjusted closing prices, without dividends, fees or taxes. Only mapped USD share positions qualify for firm estimates; options, debt and unmapped holdings are excluded. This chart covers the selected stock.

Collected Form 4 activity · 2026-06-25 – 2026-09-01. Priced non-derivative purchases and sales, including scheduled trades; excludes grants, exercises and tax withholding. These totals do not change with the chart period.

Disclosed purchases
—
No priced purchase collected
Disclosed sales
—
No priced sale collected

31 transaction lines

SEC Form 4 records. Grants, exercises, tax withholding and scheduled sales retain their labels.

CompanyActionValue
GPCRStructure Therapeutics Inc2026-09-01
Option exercise10b5-1 plan
$6.1K
GPCRStructure Therapeutics Inc2026-09-01
Conversion10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-09-01
Option exercisederivative10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-09-01
Conversionderivative10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-09-01
Salederivative10b5-1 plan
$59.6K
GPCRStructure Therapeutics Inc2026-09-01
Salederivative10b5-1 plan
$214.3K
GPCRStructure Therapeutics Inc2026-09-01
Salederivative10b5-1 plan
$4.8K
GPCRStructure Therapeutics Inc2026-08-18
Option exercise10b5-1 plan
$4K
GPCRStructure Therapeutics Inc2026-08-18
Conversion10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-08-18
Option exercisederivative10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-08-18
Conversionderivative10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-08-18
Salederivative10b5-1 plan
$160.5K
GPCRStructure Therapeutics Inc2026-08-18
Salederivative10b5-1 plan
$28.1K
GPCRStructure Therapeutics Inc2026-08-18
Salederivative10b5-1 plan
$22K
GPCRStructure Therapeutics Inc2026-08-04
Option exercise10b5-1 plan
$4K
GPCRStructure Therapeutics Inc2026-08-04
Conversion10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-08-04
Option exercisederivative10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-08-04
Conversionderivative10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-08-04
Salederivative10b5-1 plan
$152.8K
GPCRStructure Therapeutics Inc2026-08-04
Salederivative10b5-1 plan
$42K
GPCRStructure Therapeutics Inc2026-07-14
Option exercise10b5-1 plan
$8K
GPCRStructure Therapeutics Inc2026-07-14
Conversion10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-07-14
Option exercisederivative10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-07-14
Conversionderivative10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-07-14
Salederivative10b5-1 plan
$318.9K
GPCRStructure Therapeutics Inc2026-07-14
Salederivative10b5-1 plan
$82.7K
GPCRStructure Therapeutics Inc2026-06-25
Option exercise10b5-1 plan
$8K
GPCRStructure Therapeutics Inc2026-06-25
Conversion10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-06-25
Option exercisederivative10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-06-25
Conversionderivative10b5-1 plan
—
GPCRStructure Therapeutics Inc2026-06-25
Salederivative10b5-1 plan
$386.6K

Original sources

Related datasets